By Topic


Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Matthew Kelly ; Wolfson Med. Vision Lab., Oxford Univ. ; Olivier Noterdaeme ; Michael Brady

Tumor heterogeneity has major implications for tumor development and response to therapy. We relate intra-tumor heterogeneity to morphology as determined by MRI (or CT) images by applying a biologically-inspired model of tumor growth. This model represents the development of a tumor as a set of expanding spheres, each representing a distinct clonal center, with the sprouting of new spheres representing new centers. Each clonal center may possess different characteristics, including genetic composition, growth rate and response to treatment. A major implication of our work is that assessment of a tumor using volume measurements (RECIST, WHO) may not accurately reflect the response to treatment. The application of this new concept to clinical imaging studies has confirmed its ability to track and inform clinicians more accurately about changes in tumor size and morphology due to growth or therapeutic intervention.

Published in:

2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro

Date of Conference:

12-15 April 2007